AAAAAA

   
Results: 1-9 |
Results: 9
ESTIMATION OF THE INCIDENCE OF LATE BLADDER AND RECTUM COMPLICATIONS AFTER HIGH-DOSE (70-78 GY) CONFORMAL RADIOTHERAPY FOR PROSTATE-CANCER,USING DOSE-VOLUME HISTOGRAMS
Authors: BOERSMA LJ VANDENBRINK M BRUCE AM SHOUMAN T GRAS L TEVELDE A LEBESQUE JV
Citation: Lj. Boersma et al., ESTIMATION OF THE INCIDENCE OF LATE BLADDER AND RECTUM COMPLICATIONS AFTER HIGH-DOSE (70-78 GY) CONFORMAL RADIOTHERAPY FOR PROSTATE-CANCER,USING DOSE-VOLUME HISTOGRAMS, International journal of radiation oncology, biology, physics, 41(1), 1998, pp. 83-92
EO9 PHASE-II STUDY IN ADVANCED BREAST, GASTRIC, PANCREATIC AND COLORECTAL-CARCINOMA BY THE EORTC EARLY CLINICAL-STUDIES GROUP
Authors: DIRIX LY TONNESEN F CASSIDY J EPELBAUM R HUININK WWT PAVLIDIS N SORIO R GAMUCCI T WOLFF I TEVELDE A LAN J VERWEIJ J
Citation: Ly. Dirix et al., EO9 PHASE-II STUDY IN ADVANCED BREAST, GASTRIC, PANCREATIC AND COLORECTAL-CARCINOMA BY THE EORTC EARLY CLINICAL-STUDIES GROUP, European journal of cancer, 32A(11), 1996, pp. 2019-2022
A RANDOMIZED PHASE-II STUDY WITH 2 SCHEDULES OF THE NOVEL INDOLOQUINONE-EO9 IN NON-SMALL-CELL LUNG-CANCER - A STUDY OF THE EORTC EARLY CLINICAL-STUDIES GROUP (ECSG)
Authors: PAVLIDIS N HANAUSKE AR GAMUCCI T SMYTH J LEHNERT M TEVELDE A LAN J VERWEIJ J
Citation: N. Pavlidis et al., A RANDOMIZED PHASE-II STUDY WITH 2 SCHEDULES OF THE NOVEL INDOLOQUINONE-EO9 IN NON-SMALL-CELL LUNG-CANCER - A STUDY OF THE EORTC EARLY CLINICAL-STUDIES GROUP (ECSG), Annals of oncology, 7(5), 1996, pp. 529-531
FEASIBILITY, PSYCHOMETRIC PERFORMANCE, AND STABILITY ACROSS MODES OF ADMINISTRATION OF THE CARES-SF
Authors: TEVELDE A SPRANGERS MAG AARONSON NK
Citation: A. Tevelde et al., FEASIBILITY, PSYCHOMETRIC PERFORMANCE, AND STABILITY ACROSS MODES OF ADMINISTRATION OF THE CARES-SF, Annals of oncology, 7(4), 1996, pp. 381-390
THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER BREASTCANCER-SPECIFIC QUALITY-OF-LIFE QUESTIONNAIRE MODULE - FIRST RESULTS FROM A 3-COUNTRY FIELD-STUDY
Authors: SPRANGERS MAG GROENVOLD M ARRARAS JI FRANKLIN J TEVELDE A MULLER M FRANZINI L WILIAMS A DEHAES HCJM HOPWOOD P CULL A AARONSON NK
Citation: Mag. Sprangers et al., THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER BREASTCANCER-SPECIFIC QUALITY-OF-LIFE QUESTIONNAIRE MODULE - FIRST RESULTS FROM A 3-COUNTRY FIELD-STUDY, Journal of clinical oncology, 14(10), 1996, pp. 2756-2768
PHASE-II CLINICAL-TRIALS WITH RHIZOXIN IN BREAST-CANCER AND MELANOMA
Authors: HANAUSKE AR CATIMEL G AAMDAL S HUININK WT PARIDAENS R PAVLIDIS N KAYE SB TEVELDE A WANDERS J VERWEIJ J
Citation: Ar. Hanauske et al., PHASE-II CLINICAL-TRIALS WITH RHIZOXIN IN BREAST-CANCER AND MELANOMA, British Journal of Cancer, 73(3), 1996, pp. 397-399
PHASE-II STUDY OF RHIZOXIN IN SQUAMOUS-CELL HEAD AND NECK-CANCER
Authors: VERWEIJ J WANDERS J GIL T SCHOFFSKI P CATIMEL G TEVELDE A DEMULDER PHM
Citation: J. Verweij et al., PHASE-II STUDY OF RHIZOXIN IN SQUAMOUS-CELL HEAD AND NECK-CANCER, British Journal of Cancer, 73(3), 1996, pp. 400-402
SINGLE-AGENT ACTIVITY OF RHIZOXIN IN NON-SMALL-CELL LUNG-CANCER - A PHASE-II TRIAL OF THE EORTC EARLY CLINICAL-TRIALS GROUP
Authors: KAPLAN S HANAUSKE AR PAVLIDIS N BRUNTSCH U TEVELDE A WANDERS J HEINRICH B VERWEIJ J
Citation: S. Kaplan et al., SINGLE-AGENT ACTIVITY OF RHIZOXIN IN NON-SMALL-CELL LUNG-CANCER - A PHASE-II TRIAL OF THE EORTC EARLY CLINICAL-TRIALS GROUP, British Journal of Cancer, 73(3), 1996, pp. 403-405
QUALITY-OF-LIFE IN COLORECTAL-CANCER - STOMA VS NONSTOMA PATIENTS
Authors: SPRANGERS MAG TAAL BG AARONSON NK TEVELDE A
Citation: Mag. Sprangers et al., QUALITY-OF-LIFE IN COLORECTAL-CANCER - STOMA VS NONSTOMA PATIENTS, Diseases of the colon & rectum, 38(4), 1995, pp. 361-369
Risultati: 1-9 |